论文部分内容阅读
目的 康莱特注射液配合放化疗治疗肺癌 ,观察其疗效及对生存质量的影响。方法 1997年 4月至 1999年 4月治疗了 35例肺癌 ,每位患者给与康莱特注射液 10 0mlivqd× 2 0天 ,联合应用CE、EP、ACO方案化疗及常规设野放疗 ,观察治疗前后患者生活质量、体重变化及疗效。结果 治疗有效率为 6 0 %。合用康莱特治疗后 ,癌症患者的生活质量提高 ,体重增加或稳定。结论 康莱特注射液对原发性肺癌有一定的治疗作用 ,与放化疗合用 ,可提高疗效 ,改善患者生活质量。
Objective Kanglaite injection with radiotherapy and chemotherapy in the treatment of lung cancer, to observe its efficacy and quality of life. Methods From April 1997 to April 1999, 35 cases of lung cancer were treated. Each patient received Kanglaite injection at a dose of 10mlivqd × 20 days. Combined with CE, EP and ACO regimen chemotherapy and conventional radiation therapy, Quality of life, weight changes and efficacy. Results The treatment efficiency was 60%. Combined Kanglaite treatment, cancer patients improve the quality of life, weight gain or stability. Conclusions Kanglaite Injection has a certain therapeutic effect on primary lung cancer, combined with radiotherapy and chemotherapy, can improve the curative effect and improve the quality of life of patients.